A kind of pharmaceutical composition for anti-gastrointestinal cancer

Abstract

The invention discloses a pharmaceutical composition for resisting gastrointestinal cancer. The pharmaceutical composition comprises the following components in parts by weight: 4-8 parts of Hericium erinaceus mycelium; 4-8 parts of solanum nigrum; The pharmaceutical composition of the present invention also includes notoginseng, privet fruit and tangerine peel, and the weight parts of the notoginseng, privet fruit and tangerine peel are all 1-3 in the pharmaceutical composition. In the present invention, Hericium erinaceus mycelium is compatible with black nightshade and stinky peony, and Sanqi, Ligustrum lucidum and orange peel can also be added to produce unexpected technical effects, and the anti-gastrointestinal cancer effect is remarkable. Compared with Hericium erinaceus alone, the activity of the pharmaceutical composition of the present invention is higher; in vivo and in vitro anti-tumor tests have not seen any toxic and side effects, and the pharmaceutical composition of the present invention is safe to use and can be used to prepare anti-gastrointestinal cancer drug.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a pharmaceutical composition for resisting gastrointestinal cancer. Background technique [0002] Gastrointestinal cancer is one of the common malignant tumors, accounting for about 25% of all cancers according to the American Cancer Society. Gastrointestinal cancer ranks fourth in the incidence of cancer in the world, and China has a high incidence and mortality rate (50% of the death cases occur in China). The treatment of gastrointestinal cancer includes surgery, chemical drug therapy, Radiation therapy and immunotherapy. Chemotherapy is the most commonly used method, but it cannot be cured completely, and its toxic and side effects are relatively large. In the past few decades, the development of molecular biology has made some progress in the treatment of gastrointestinal cancer, but drug resistance and toxicity still limit the progress of treatment me...

AI Technical Summary

Problems solved by technology

However, there are only more than 20 species that are widely used in clinical practice, and the 2015 edition of the "Chinese Pharmacopoeia" clearly included 7 species, which shows that the research on biological medicinal bacteria is still far from perfect, and there is a lot of room for development.

Images